{"pub_date": "2016-05-17T00:00:00Z", "subsection_name": null, "lead_paragraph": "The company said hospitals would be eligible for a discount of 10 percent to 40 percent on the heart drugs Nitropress and Isuprel.", "print_page": "3", "document_type": "article", "byline": {"person": [{"rank": 1, "organization": "", "lastname": "THOMAS", "firstname": "Katie", "role": "reported"}], "original": "By KATIE THOMAS"}, "multimedia": [{"width": 190, "height": 126, "url": "images/2016/05/17/business/17valeant/17valeant-thumbWide.jpg", "subtype": "wide", "legacy": {"wide": "images/2016/05/17/business/17valeant/17valeant-thumbWide.jpg", "widewidth": "190", "wideheight": "126"}, "type": "image"}, {"width": 600, "height": 393, "url": "images/2016/05/17/business/17valeant/17valeant-articleLarge.jpg", "subtype": "xlarge", "legacy": {"xlargewidth": "600", "xlargeheight": "393", "xlarge": "images/2016/05/17/business/17valeant/17valeant-articleLarge.jpg"}, "type": "image"}, {"width": 75, "height": 75, "url": "images/2016/05/17/business/17valeant/17valeant-thumbStandard.jpg", "subtype": "thumbnail", "legacy": {"thumbnail": "images/2016/05/17/business/17valeant/17valeant-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "type": "image"}], "section_name": "Business Day", "headline": {"print_headline": "Valeant Expands Drug Discount Offer After Criticism", "main": "Valeant Pharmaceuticals Expands Drug Discount Offer After Criticism"}, "source": "The New York Times", "blog": [], "word_count": "835", "web_url": "http://www.nytimes.com/2016/05/17/business/valeant-pharmaceuticals-expands-drug-discount-offer-after-criticism.html", "slideshow_credits": null, "news_desk": "Business", "type_of_material": "News", "snippet": "The company said hospitals would be eligible for a discount of 10 percent to 40 percent on the heart drugs Nitropress and Isuprel.", "_id": "5739e16738f0d83bc1f16560", "abstract": "Valeant Pharmaceuticals International unveils new plan that simplifies and expands its previous discount program for two heart medications, Nitropress and Isuprel; announcement follows Congressional hearings on complaints firm failed in its 2015 pledge to give price cuts to hospitals and large purchasers.", "keywords": [{"rank": "1", "name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "is_major": "Y"}, {"rank": "2", "name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y"}]}